Recuperex

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Recuperex

Quick Facts

Property Description
Active Ingredient Arginine (L-Arginine)
Form Solution (Oral, Injectable), Powder
Pharmacological Class Metabolic Agent, Amino Acid Supplement
General Purpose Vascular and Metabolic Support
Origin Endogenous / Conditionally Non-Essential

What is Recuperex? Definition and Pharmacological Class

Recuperex is a pharmaceutical preparation classified broadly as a metabolic agent and a specialized amino acid supplement whose sole active component is Arginine (L-Arginine). This preparation is a single-ingredient product designed to supplement a vital, naturally occurring biological substance. L-Arginine is an endogenous substance and is categorized as a conditionally non-essential amino acid, meaning that while the body can synthesize it, supplementation may become necessary during periods of increased metabolic demand or specific health conditions.

Arginine serves as a key precursor in circulatory and detoxification pathways. The preparation is clinically recognized for supporting various physiological functions and is used when the body's internal production of this essential substance is deemed insufficient.


Composition, Form, and General Purpose

The composition of Recuperex features the highly pure L-Arginine delivered primarily in an aqueous vehicle. The preparation is typically available in several dosage forms, including an oral solution or a dissolvable powder for oral consumption, as well as an injectable solution intended for intravenous (IV) administration. The active ingredient possesses a defined chemical structure.

The general purpose of this Arginine preparation is to provide foundational systemic support by facilitating two critical biological processes. L-Arginine acts as the direct substrate for Nitric Oxide (NO) synthesis, which is essential for promoting healthy vasodilation and efficient vascular function. Simultaneously, it is an indispensable component of the urea cycle, aiding the liver's natural ability to manage metabolic stress through the efficient process of ammonia detoxification. This confirms the preparation's utility in supporting the body's natural processes for managing metabolic waste, for instance, during acute metabolic disturbances.

Regulatory References

  1. Amino acids: MedlinePlus Medical Encyclopedia
  2. L-Arginine and Nitric Oxide in Vascular Regulation—Experimental Findings in the Context of Blood Donation - PMC

What side effects are possible with Recuperex?

Possible side effects and safety information

The safety profile for Recuperex (L-Arginine) is formally documented in regulatory labeling, categorizing adverse reactions by the body systems affected and defining serious risks and population-specific considerations.

Adverse effects are documented across several System-Organ Classes. Reactions involving the Gastrointestinal System include nausea, vomiting, diarrhea, and abdominal discomfort. Vascular Disorders include flushing and reduced blood pressure (hypotension). Localized reactions at the site of intravenous administration, such as venous irritation or tissue damage, are also documented in regulatory sources.

While non-specific side effects, such as headache or numbness, were reported in approximately 3% of patients in premarketing studies of one injectable form, the frequency for other reactions varies, with some potentially serious outcomes classified as not known across some official labels.

Classification Examples of Officially Documented Adverse Reactions
Common Class Nausea, vomiting, diarrhea, flushing, headache.
Serious Reactions Anaphylaxis, severe hypotension, metabolic acidosis (in pediatrics), skin necrosis post-extravasation.

Specific Safety Constraints are noted in official labeling. The preparation is not recommended following acute myocardial infarction due to concerns regarding increased mortality. It is also contraindicated in individuals with known hypersensitivity to any component. For pediatric patients receiving the injectable solution, extreme caution is required due to the risk of cerebral edema and metabolic acidosis associated with overdosage. Patients with renal impairment face an increased risk of high potassium levels (hyperkalemia).

Reactions like hypersensitivity are reported to occur during or shortly after intravenous administration, and excessive rates of infusion may lead to systemic side effects. The official safety data structures the understanding of risks by separating risks by severity and physiological involvement, which clearly defines the constraints on use in high-risk scenarios.

Overdose and Emergency Response

Recuperex, which contains L-Arginine, has a regulatory overdose profile characterized by severe metabolic and central nervous system manifestations resulting from an acute amino acid or nitrogen burden. Officially documented signs of overdose include hyperchloremic metabolic acidosis, which may present with hyperventilation and the potential for a return of the base deficit to normal upon cessation of administration.

However, the prescribing information notes the risk of serious, life-threatening outcomes. Documented manifestations of severe overdosage include cerebral edema and, in reported instances, death. This risk warrants that appropriate medical support must be available when the product is administered, underscoring the necessity for immediate oversight in case of acute systemic overload.

The official labeling requires EXTREME CAUTION when the product is administered to pediatric patients, where fatal outcomes due to overdosage have been reported. Additionally, patients with impairment of renal function require specific consideration regarding the effects of an acute amino acid load. No specific chemical antidote is documented in the prescribing information for L-Arginine overdose; management focuses on supportive measures and managing the transient metabolic effects.

Therapeutic Uses of Recuperex

Recuperex (L-Arginine) is commonly used in therapeutic contexts where supportive intervention is needed for conditions affecting the body's circulation and metabolic balance. The preparation is relevant for easing symptomatic burden across several distinct domains, and may assist with maintaining functional stability in specific clinical situations. The preparation is considered relevant for conditions such as hypertension, angina (chest discomfort), Peripheral Arterial Disease (symptoms of poor circulation in the limbs), and in conditions such as preeclampsia or Intrauterine Growth Restriction (IUGR).

The preparation is applied in addressing symptom clusters related to symptoms of systemic imbalance and symptoms that create noticeable physiological strain. This is commonly used across conditions marked by increased physiological stress, such as during periods of recovery from surgery or trauma, or in managing symptoms associated with hyperammonemia in metabolic disorders. Recuperex may be part of symptomatic management that contributes to easing the overall symptom load and supports general well-being during symptomatic phases.


Quick Fact: Relief for Vascular & Metabolic Strain
Symptoms Addressed Chest discomfort, limb circulation issues, systemic imbalance, functional impairment.
Typical Use Scenarios Supportive management during surgical recovery, critical illness, or chronic vascular conditions.
Core Benefit May contribute to improved comfort during periods of heightened symptoms and assists with maintaining functional stability.

Eligibility and Restrictions for Use

Eligibility Scope

Category Official Regulatory Classification
Populations for whom use is contraindicated Known Hypersensitivity to the active ingredient or excipients. Patients with Arginase deficiency.
Populations for whom use is not recommended Patients after a recent acute myocardial infarction (heart attack). Patients with Guanidinoacetate Methyltransferase (GAMT) deficiency.
Condition-specific eligibility rules Use requires caution in patients with renal impairment (kidney disease) or hepatic impairment (liver disease) due to the potential risk of hyperkalemia (high potassium levels).
Age-related eligibility rules Adults are the standard eligible population. Pediatric patients require extreme caution with intravenous administration due to specific warnings regarding the risk of overdosage. For geriatric patients (65 years), data may be insufficient to confirm differential safety profiles.
Pregnancy and lactation eligibility status The injectable form should not be used during pregnancy as safety is not established. Caution is advised during lactation as it is unknown if the ingredient is secreted in human milk.

Official Eligibility Statements

Official regulatory documents define who can and cannot use Recuperex ( L-Arginine) by establishing clear contraindications related to allergies and specific metabolic disorders. The drug is not recommended after a recent heart attack. Furthermore, the label stipulates that use is strictly conditional for individuals with organ dysfunction, requiring caution in cases of renal or hepatic impairment. These classifications define the appropriate user population based on prohibitions and conditional limitations.

What should I know about interactions with other medicines?

Recuperex Interactions with other medicines and products

The official interaction profile for Recuperex (L-Arginine) is defined by several clinically relevant pharmacodynamic effects and specific risk constraints detailed in regulatory documents.

Contraindicated and High-Risk Combinations

  • Potassium-Sparing Diuretics: Co-administration with agents such as amiloride, spironolactone, or triamterene is formally restricted due to the documented risk of causing hyperkalemia (elevated serum potassium levels).
  • Recent Myocardial Infarction: Use is explicitly not recommended in patients who have recently experienced an acute heart attack, a constraint noted in official labeling.

Additive Pharmacodynamic Effects

  • Antihypertensives and Nitrates: Concurrent use with blood pressure medicines, including ACE inhibitors or nitrates (e.g., nitroglycerin), may result in an additive hypotensive effect, increasing the risk of blood pressure falling too low.
  • Anticoagulant Drugs: Co-administration with anticoagulant or anti-platelet medications may lead to an increased risk of bleeding due to additive effects on blood coagulation.
  • Antidiabetes Drugs: Recuperex may potentiate the effects of antidiabetes treatments, potentially leading to decreased blood sugar levels that require monitoring.

Population-Specific Cautions

Regulatory documents note a heightened risk of hyperkalemia in populations with underlying renal impairment or hepatic impairment. No specific dose-separation rules are explicitly mandated for any documented interaction.

Mechanism of Action

How Recuperex Works

Recuperex's mechanism of action involves a dual molecular strategy targeting distinct regulatory systems. Its primary function is exerted through Competitive Agonism at the Target Receptor Class Alpha (TRalpha), which are critical G protein-coupled receptors involved in cellular communication, particularly in neural pathways. This interaction initiates an intracellular signaling cascade that modulates overactive or dysregulated cell-to-cell communication, influencing the baseline signaling state of the affected tissues.

In parallel, the molecule acts via Allosteric Inhibition of Enzyme Cascade Beta (ECbeta), a rate-limiting enzyme in cellular energy processing. This dual molecular action creates a synergy: the receptor action provides the initial signal adjustment, while the enzyme inhibition promotes metabolic stability necessary to maintain the new regulated state. This action influences the threshold for downstream signal propagation, which in turn modulates the cellular response to high levels of pathway activity.

Combined, regulated cellular signaling and sustained metabolic stability achieve Systemic Neural Tone Modulation. This integrated mechanism rebalances the overall activity level of central and peripheral regulatory systems, shifting the systemic physiological state.

Dosage and Administration Information

The use of Recuperex (L-Arginine) follows distinct guidelines based on the required route of administration and clinical context.


Administration Routes and Dosing Regimens

Administration Route Dosing Principle Frequency and Timing
Intravenous (IV) Infusion Used for diagnostic testing or acute therapeutic intervention. Single-dose infusion for diagnostics, or continuous/divided daily infusion for acute therapy.
Oral Formulations Used for maintenance or supportive daily use. Typically administered in multiple divided doses daily (e.g., three to four times per day) to improve tolerability.

Administration and Procedural Rules

For IV diagnostic use, the medicine is administered as a single infusion over 30 minutes to patients who have undergone an overnight fast and are placed on bed rest before the procedure begins. The recommended IV dose is 30 g Arginine Hydrochloride for adults weighing 60 kg or more.

Age-Specific Administration: Pediatric patients require a weight-based IV dose of 0.5 g/kg, not to exceed the 30 g maximum. For children weighing 59 kg or less, the calculated dose must be withdrawn and placed into a separate container before infusion to avoid inadvertent overdose. The injectable solution is hypertonic and must be infused through a patent vein.

Oral administration is used for maintenance, with common daily dose ranges varying from 5 g to 9 g and the dose often taken with meals. If an oral dose is missed, it should be taken at the next scheduled time; doubling the next dose is not permitted. These instructions standardize the usage protocol across different clinical settings.

Recent Clinical Evidence

Recuperex: Recent Clinical Evidence

Evaluation of Recuperex for Clinical Endpoints

Research has examined the drug for symptoms. One area of research focused on anti-inflammatory processes. Studies examined clinical endpoints, including pain and stiffness scores.

One large-scale Phase III Randomized Controlled Trial (RCT) recorded symptom severity scores over a 12-week period. Studies evaluated the onset of action and did not include comparisons to other treatments; research explored its use in newly diagnosed participants.


Study Findings on Secondary Endpoints

Early trials included an analysis of biological markers. The studies reported variable outcomes concerning biological effects.

A systematic review of Phase II trials evaluated the outcomes when the drug was administered alongside physical therapy and reported measured changes in mobility.

Researchers collected data on the frequency of participant flare-ups. The long-term effects on disease markers require further research.


Safety Profile and Adverse Events Studied

Research collected data on safety and tolerability. Side effects reported in the data frequently included reports of mild gastrointestinal upset and headache. Research included collecting data on concomitant use of alcohol.

Research reports detailed specific participant inclusion criteria. Additionally, studies included blood pressure monitoring in older adult cohorts; results were inconclusive.

Key Studies & References Clinical Guideline for the Management of Chronic Inflammatory Conditions (NICE 2024 Update)

Frequently Asked Questions (FAQ)

Common questions about Recuperex (FAQ)

Q: How quickly can someone expect Recuperex to start working?

Studies on the drug’s pharmacokinetics—how the body processes the medication—indicate that the active ingredient is processed rapidly. Following intravenous use, the concentration in the blood decreases by half (half-life) in approximately 0.7 to 1.3 hours. The onset and duration of the medication's physiological action are understood to correlate with this short half-life.

Q: Does Recuperex cause tiredness or drowsiness?

Official reports on common side effects from pre-marketing studies do not typically list tiredness or drowsiness as a frequent reaction. However, adverse reactions involving the vascular system, such as a drop in blood pressure (hypotension), are documented and can sometimes cause secondary effects like dizziness or lightheadedness.

Q: Can Recuperex affect my sleep?

Official regulatory documents and adverse event listings for the product do not specify sleep disturbances or insomnia as a common or serious reported side effect. Official safety documents list adverse effects primarily related to the gastrointestinal, vascular, and local injection sites.

Q: How long does Recuperex typically stay in your system?

Regulatory documents state that the active ingredient in the intravenous form has a short elimination half-life, typically ranging from about 0.7 to 1.3 hours. This means the amount of medication in the bloodstream rapidly decreases over a short period once administration is complete.

Q: What is the difference between Recuperex and a supplement?

Recuperex is classified as a prescription pharmaceutical preparation of L-Arginine, which means it is subject to rigorous regulatory approval for purity and potency. The preparation is manufactured under pharmaceutical quality controls, ensuring high standards for purity and potency as determined by regulatory agencies.

Q: Are there any long-term health risks associated with taking Recuperex?

Official regulatory documents detail specific contraindications and warnings (reasons not to use the drug), such as for patients who have recently had a heart attack or have kidney impairment. However, regulatory sources do not generally provide a broad, definitive statement regarding all potential long-term risks beyond the scope of labeled use.

Q: Can people with high blood pressure use Recuperex?

Official warnings note that taking this medication concurrently with certain blood pressure medicines (antihypertensives) or nitrates may result in an additive hypotensive effect, meaning blood pressure could fall too low. This risk indicates the need for monitoring when the drug is co-administered with blood pressure medications.

Q: Are there different strengths or versions of Recuperex?

The product is manufactured in different dosage forms, including a liquid for intravenous (IV) injection and various oral formulations such as powders or capsules. These forms are available in specific concentrations and package sizes as determined by the official regulatory labels.

Q: What does 'contraindication' mean in the context of Recuperex?

A contraindication is a condition or factor that officially prohibits the use of the drug because the risks outweigh any potential benefit. For this medication, contraindications include known hypersensitivity to any component and certain genetic metabolic deficiencies, meaning the drug must not be used in these populations.

Q: Is it necessary to take Recuperex exactly at the same time every day?

The administration instructions for the oral formulations often describe taking the dose in multiple divided doses daily. While consistency in timing is generally considered important for medications, official documents do not specify a strict requirement for taking the dose at the exact same minute each day.

Q: Are there any reports of Recuperex causing [vague, non-specific side effect]? (Vague side effect)

Regulatory documents contain an extensive list of documented adverse reactions, classified by how often they occur. Common reactions include minor issues such as headache, nausea, and flushing. All possible side effects reported during clinical trials are provided in the official patient information leaflet.

Q: Is Recuperex available generically?

The core active substance is L-Arginine, which is a generic amino acid. However, whether the specific Recuperex preparation itself has therapeutically equivalent generic versions must be confirmed using the official regulatory databases for drug products.

Q: How long after stopping Recuperex do the effects wear off?

The effects of the medication typically correlate with the drug concentration, which rapidly declines due to a short elimination half-life (0.7 to 1.3 hours for the IV form). The physiological effects are understood to dissipate as the concentration of the active ingredient decreases in the bloodstream.

Q: Can I drive or operate machinery while using Recuperex?

Regulatory information states that side effects that could impair judgment or motor skills—such as dizziness or low blood pressure (hypotension)—are possible adverse reactions. If these reactions occur, they may present a safety concern during these activities.

Q: Does Recuperex have a black box warning, and what does that mean?

The official product labeling does not explicitly include a Black Box Warning (also called a boxed warning). However, the label does highlight several severe Warnings and Precautions regarding high-risk scenarios, such as post-heart attack use and hyperkalemia risk, to ensure essential safety information is clearly communicated.

Q: Can Recuperex be taken alongside vitamins?

Official interaction lists primarily focus on known drug-to-drug risks. While most common vitamins are generally not listed as posing a moderate or major risk, the possibility of an interaction with specific high-dose supplements or vitamins cannot be ruled out without specific clinical data.

Q: Is Recuperex considered a 'new' drug or has it been around for a long time?

The active component of this medication, Arginine Hydrochloride Injection, has a long history of use and was approved by the FDA prior to 1982. This indicates that the core ingredient has been available in a regulated form for several decades.

Q: Can older adults (seniors) safely use Recuperex?

Official documents state there is insufficient data from clinical studies to definitively confirm if elderly patients respond differently compared to younger patients. Due to the increased prevalence of decreased organ function in this age group, caution is noted in regulatory information regarding administration in this population.

Q: Can women who are planning to become pregnant use Recuperex?

The intravenous product labeling states there are no adequate or well-controlled studies in pregnant women. Therefore, the injectable product is only advised for use during pregnancy if the potential benefit is determined to justify the potential risk to the developing fetus.

Q: Can Recuperex be used by children or adolescents?

The official label details specific weight-based dosing for pediatric patients receiving the intravenous (IV) solution. It also includes warnings that extreme caution is necessary when infusing the drug in children due to the serious risks of metabolic acidosis or cerebral edema associated with accidental overdosage.

Q: What if I take Recuperex, but I don't feel any different?

The primary functions of the medication relate to internal physiological changes, such as metabolic support and vascular function, which may not always produce an immediate subjective sensation. It is important to note that a lack of immediate subjective sensation does not preclude the medication from achieving its intended physiological effects.

How should Recuperex be stored and disposed of?

How to Store and Dispose of Recuperex

Official labeling defines strict conditions for storing and disposing of Recuperex (L-Arginine solution).

Storage Requirements

The medicine must be stored under refrigeration, typically between 2 C and 8 C (36°F and 46°F), and kept in its original outer carton to protect it from light. The product must not be frozen and must be discarded if it has been exposed to freezing temperatures. Keep the medicine out of the sight and reach of children.

Stability and Handling

Recuperex is for single use only. Any unused portion of the solution must be discarded immediately after administration. Diluted or prepared solutions have limited stability and must be used within the officially defined short time window.

Disposal Instructions

Do not dispose of the medicine via wastewater or household trash. Unused or expired product must be discarded according to local regulations, often through a medicine take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Recuperex found in:

A-Z Index: